CRISPR Therapeutics AG CRSP
48.44 USD -3.34 (-6.44%)
Nov 5, 2026, 2:27 PM EST
48.06 Day range 51.21
44.12 52-week range 63.45
- YTD
- -7.63%
- 1 year
- -15.00%
Held by funds
115 US ETFs and mutual funds hold CRSP · largest positions
Ownership
Held by insiders 5.95%
Held by institutions 77.79%
Float held by institutions 82.71%
Institutions 682
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Investment Management, LLC | 9.75% | 9,460,939 | 489.84M | Jun 29, 2026 |
| Blackrock Inc. | 8.61% | 8,348,977 | 432.27M | Jun 29, 2026 |
| Orbis Allan Gray Ltd | 5.62% | 5,449,161 | 282.13M | Jun 29, 2026 |
| Capital World Investors | 4.90% | 4,749,525 | 245.91M | Jun 29, 2026 |
| State Street Corporation | 4.46% | 4,321,666 | 223.75M | Jun 29, 2026 |
| GSK plc | 3.32% | 3,220,627 | 166.75M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 6.77% | 6,568,594 | 340.09M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.80% | 2,716,415 | 140.64M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.40% | 2,325,509 | 120.40M | Sep 29, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 2.20% | 2,133,972 | 110.49M | Sep 29, 2026 |
| NEW PERSPECTIVE FUND | 2.00% | 1,944,073 | 100.65M | Sep 29, 2026 |
| SmallCap World Fund Inc | 1.75% | 1,694,327 | 87.72M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEHBAHANI ALI | Director | Sale | Sep 16, 2026 | 16,666 |
| BRUNO JULIANNE | Chief Operating Officer | Sale | Mar 20, 2025 | 17,632 |
| GEORGE SIMEON J. | Director | Purchase | Jul 15, 2025 | 0 |
| GREENE JOHN THOMAS | Director | Purchase | Feb 25, 2025 | 7,000 |
| KASINGER JAMES R. | General Counsel | Sale | Oct 5, 2026 | 94,784 |
| KULKARNI SAMARTH | Chief Executive Officer | Sale | Oct 18, 2026 | 311,899 |